Experimental approach for gene therapy of pulmonary emphysema focusing on Klotho gene and GSTP1 gene

以Klotho基因和GSTP1基因为中心的肺气肿基因治疗实验方法

基本信息

  • 批准号:
    15590799
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2004
  • 项目状态:
    已结题

项目摘要

The gene polymorphism of exon 5 of glutathione S-transferases P1 (GSTP1) may predispose a smoker to the development of COPD. However, the direct association of the GSTP1 polymorphism and the development of emphysematous alteration of lungs after cigarette smoke exposure have not been examined. We examined the effects of chronic smoke inhalation on the function and morphology of lungs in mice lacking glutathione S -transferases P1/P2 (GSTP1). After 16 weeks of cigarette smoke exposure, a significant airspace size enlargement along with a leftward shift of the pressure-volume (P-V) curve was observed in GSTP1/2 null mice but not in control mice, when compared with the same strain of mice with air exposure. Biochemical analysis revealed that chronic smoke exposure caused protease-antiprotease imbalance and oxidant-antioxidant imbalance in GSTP1/P2 null mouse.The results suggest that disruption of glutathione S-transferases pi class is susceptible to cigarette smoke-induced airway disease … More through protease-antiprotease imbalance and oxidant-antioxidant imbalance in mice.Each puff of a cigarette contains 1017 free radicals and about 4000 substrates including carcinogenic agents and other possible causative agents of COPD such as volatile aldehydes and hydrogen cyanide. Thus defects in the detoxification of these reactive species may predispose smokers to airflow obstruction and emphysema. Indeed the patients with slow mEPHX activity was significantly higher in patients with COPD, when compared to healthy controls. These findings have been supported by Pare and colleagues, who have assessed a well-characterized cohort of patients from the Lung Health Study.We have reported that the genetic polymorphism of exon 5 of smokers with of glutathione S-transferase P1 (GSTP1) is associated with the development of COPD in smokers. Because the GSTP1/Ile105 genotype is predominantly found in COPD (72%), but not in smokers without airflow limitation (52%), the GSTP1/Ile105 genotype may be less protective against xenobiotics in tobacco smoke. The recent data further supports that GSTP1/Ile105 homozygote is associated with an increase in IgE and histamine after challenge with diesel exhaust particles and allergens. Although cigarette smoking is the most important risk factor for the development of COPD, allergic airway inflammation, long-standing asthma, air pollutants, diesel exhaust particles, and xenobiotics may also cause irreversible airflow limitation such as COPD. It has been reported that the tunnel workers being exposed to gases and particles from blasting and diesel exhausts are likely to develop COPD (9). Therefore, subjects exposed to diesel exhaust particles are susceptibile to accelerated decline of lung function, resulting in COPD. There is growing evidence for the role of xenobiotics and antioxidant imbalance in the pathogenesis of airflow obstruction, which is supported by association studies between COPD and variants in epoxide hydrolase and GSTs that detoxify free radicals and other tobacco products (10-14). Before these associations are generally accepted, they must be subjected to scrutiny with further association studies in terms of ethnicity and COPD phenotypes. Less
谷胱甘肽S-转移酶P1(GSTP 1)第5外显子基因多态性可能是吸烟者发生COPD的易感基因。然而,GSTP 1多态性和吸烟后肺气肿改变的发展之间的直接联系尚未得到研究。我们研究了慢性烟雾吸入对谷胱甘肽S -转移酶P1/P2(GSTP 1)缺乏小鼠肺功能和形态的影响。香烟烟雾暴露16周后,与暴露于空气中的同品系小鼠相比,在GSTP 1/2敲除小鼠中观察到显著的空域尺寸增大沿着,压力-容积(P-V)曲线显著移位,但在对照小鼠中未观察到。生化分析表明,慢性烟雾暴露导致GSTP 1/P2基因敲除小鼠蛋白酶-抗蛋白酶失衡和氧化剂-抗氧化剂失衡,提示谷胱甘肽S-转移酶pi类的破坏是香烟烟雾诱导的气道疾病的易感因素 ...更多信息 通过蛋白酶-抗蛋白酶失衡和氧化剂-抗氧化剂失衡在小鼠中进行。每口香烟含有1017个自由基和大约4000个底物,包括致癌剂和其他可能导致COPD的物质,如挥发性醛和氰化氢。因此,这些活性物质的解毒缺陷可能使吸烟者容易发生气流阻塞和肺气肿。事实上,与健康对照组相比,COPD患者中mEPHX活性缓慢的患者显著更高。这些发现得到了帕雷及其同事的支持,他们评估了一组来自肺部健康研究的患者,我们报道了吸烟者谷胱甘肽S-转移酶P1(GST P1)外显子5的遗传多态性与吸烟者COPD的发生有关。由于GSTP 1/Ile 105基因型主要见于COPD(72%),而非无气流限制的吸烟者(52%),因此GSTP 1/Ile 105基因型对烟草烟雾中的外源性物质的保护性可能较低。最近的数据进一步支持GSTP 1/Ile 105纯合子与柴油机排气颗粒和过敏原激发后IgE和组胺的增加相关。虽然吸烟是COPD发展的最重要的危险因素,但过敏性气道炎症、长期哮喘、空气污染物、柴油机废气颗粒和外源性物质也可能导致不可逆的气流限制,如COPD。据报,隧道工人暴露于爆破和柴油废气产生的气体和颗粒,很可能患上慢性阻塞性肺病(9)。因此,暴露于柴油机排气颗粒的受试者容易加速肺功能下降,导致COPD。越来越多的证据表明外源性物质和抗氧化剂失衡在气流阻塞的发病机制中的作用,这得到了COPD与环氧化物水解酶和GST(可使自由基和其他烟草产品解毒)变体之间的关联研究的支持(10-14)。在这些相关性被普遍接受之前,必须对它们进行进一步的种族和COPD表型相关性研究的审查。少

项目成果

期刊论文数量(68)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nutritional deficiency affects cell cycle status and viability in A549 cells : role of p27Kipl.
营养缺乏影响 A549 细胞的细胞周期状态和活力:p27Kipl 的作用。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ishii T;et al.
  • 通讯作者:
    et al.
Ubstructive sleep apnea causes systemic inflammation and metabolic syndrome.
阻塞性睡眠呼吸暂停会导致全身炎症和代谢综合征。
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Teramoto.S.;et al.
  • 通讯作者:
    et al.
Xenobiotic enzymes and geneties of COPD.
COPD 的异生酶和基因。
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Teramoto;S.;et al.
  • 通讯作者:
    et al.
Apoptosis of Circulating Neutrophils and Alveolar Macrophages in COPD.
COPD 中循环中性粒细胞和肺泡巨噬细胞的凋亡。
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Teramoto;S.;et al.
  • 通讯作者:
    et al.
Teramoto S, et al.: "Nosocomial infections in adult intensive-care units."Lancet. 364. 493-493 (2003)
Teramoto S 等人:“成人重症监护病房中的医院感染。”柳叶刀。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TERAMOTO Shinji其他文献

TERAMOTO Shinji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TERAMOTO Shinji', 18)}}的其他基金

Influences of sleep apnea on the progression of atherosclerosis, metabolic syndrome, and vascular diseases : inhibitory roles of CPAP on the prevention of vascular diseases
睡眠呼吸暂停对动脉粥样硬化、代谢综合征和血管疾病进展的影响:CPAP 对预防血管疾病的抑制作用
  • 批准号:
    17590781
  • 财政年份:
    2005
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

ICF: A novel dual-target gene therapy for safe and efficacious treatment of chronic non-infectious uveitis
ICF:一种安全有效治疗慢性非感染性葡萄膜炎的新型双靶点基因疗法
  • 批准号:
    MR/Z50385X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Research Grant
Next-generation automation and PAT implementation for QbD and enhanced approaches for cell and gene therapy
QbD 的下一代自动化和 PAT 实施以及细胞和基因治疗的增强方法
  • 批准号:
    10087446
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Collaborative R&D
Longitudinal structural and cognitive functional imaging and outcome prediction in focal epilepsy treated with gene therapy and surgical resection.
基因治疗和手术切除治疗局灶性癫痫的纵向结构和认知功能成像及结果预测。
  • 批准号:
    MR/X031039/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Research Grant
Phase I/II clinical trial of autologous T cell gene therapy to treat X-linked lymphoproliferative disease (XLP)
自体T细胞基因疗法治疗X连锁淋巴增殖性疾病(XLP)的I/II期临床试验
  • 批准号:
    MR/Y019458/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Research Grant
GeneT: The Gene Therapy CoE at the Center of Portugal
GeneT:葡萄牙中心的基因治疗 CoE
  • 批准号:
    10090933
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
    EU-Funded
Developing a gene therapy product to treat pressure ulcers in lower-limb amputees
开发一种基因治疗产品来治疗下肢截肢者的压力性溃疡
  • 批准号:
    2888189
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Studentship
Activation of long non-coding RNA by a gene therapy CRISPR/Cas9 approach to prevent vein graft failure
通过基因治疗 CRISPR/Cas9 方法激活长非编码 RNA 以预防静脉移植失败
  • 批准号:
    EP/X024563/1
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Research Grant
SBIR Phase I: Development of an Adjustable Gene Therapy Platform Technology
SBIR 第一阶段:可调节基因治疗平台技术的开发
  • 批准号:
    2240683
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Standard Grant
Exploration novel effects of SHED-TK-derived exosomes on TK/GCV suicide gene therapy
探索SHED-TK衍生的外泌体对TK/GCV自杀基因治疗的新作用
  • 批准号:
    23K15643
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Gene expression profiling of skin ulcers for short-acting in vivo gene therapy
皮肤溃疡的基因表达谱用于短效体内基因治疗
  • 批准号:
    23K19673
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了